Transamniotic Stem Cell Therapy Modulates Uterine Natural Killer Cell Activity in the Hypoxia Model of Intrauterine Growth Restriction
Stem Cells and Development · 2024
DOI: 10.1089/scd.2023.0282 ↗Kurz gefasst
Fachartikel in der Zeitschrift Stem Cells and Development, 2024. Verfasst von Ashlyn E Whitlock und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Boston Children's Hospital/Harvard Medical School, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Fetal Growth Retardation, Killer Cells, Natural, Rats, Sprague-Dawley, Uterus. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, Boston Children's Hospital/Harvard Medical School, Boston, Massachusetts, USA.
ORCID-Profile: Dario O Fauza
Zitieren
APA
Whitlock, A. E., Moskowitzova, K., Kycia, I., Zurakowski, D., & Fauza, D. O. (2024). Transamniotic Stem Cell Therapy Modulates Uterine Natural Killer Cell Activity in the Hypoxia Model of Intrauterine Growth Restriction. Stem Cells and Development. https://doi.org/10.1089/scd.2023.0282
Vancouver
Whitlock AE, Moskowitzova K, Kycia I, Zurakowski D, Fauza DO. Transamniotic Stem Cell Therapy Modulates Uterine Natural Killer Cell Activity in the Hypoxia Model of Intrauterine Growth Restriction. Stem Cells and Development. 2024. doi:10.1089/scd.2023.0282
BibTeX
@article{Whitlock2024,
author = {Whitlock, Ashlyn E and Moskowitzova, Kamila and Kycia, Ina and Zurakowski, David and Fauza, Dario O},
title = {Transamniotic Stem Cell Therapy Modulates Uterine Natural Killer Cell Activity in the Hypoxia Model of Intrauterine Growth Restriction},
journal = {Stem Cells and Development},
year = {2024},
doi = {10.1089/scd.2023.0282}
}
EUVIMED